Q2 Earnings Forecast for Enhabit Issued By Leerink Partnrs

Enhabit, Inc. (NYSE:EHAB) – Equities researchers at Leerink Partnrs issued their Q2 2025 EPS estimates for shares of Enhabit in a research report issued on Sunday, May 11th. Leerink Partnrs analyst W. Mayo anticipates that the company will post earnings per share of $0.11 for the quarter. The consensus estimate for Enhabit’s current full-year earnings is $0.22 per share. Leerink Partnrs also issued estimates for Enhabit’s Q3 2025 earnings at $0.11 EPS, Q4 2025 earnings at $0.10 EPS, FY2025 earnings at $0.42 EPS, Q4 2026 earnings at $0.11 EPS, FY2026 earnings at $0.47 EPS and FY2027 earnings at $0.37 EPS.

Enhabit (NYSE:EHAB) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.03. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The firm had revenue of $259.90 million during the quarter, compared to analysts’ expectations of $266.11 million.

Separately, Jefferies Financial Group reaffirmed a “buy” rating on shares of Enhabit in a research note on Thursday, March 6th.

Enhabit Price Performance

EHAB stock opened at $10.50 on Wednesday. Enhabit has a 12 month low of $6.85 and a 12 month high of $10.70. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. The company has a 50-day moving average price of $8.41 and a 200 day moving average price of $8.13. The stock has a market cap of $531.69 million, a PE ratio of -4.53 and a beta of 1.61.

Institutional Investors Weigh In On Enhabit

Several large investors have recently added to or reduced their stakes in EHAB. GAMMA Investing LLC boosted its position in Enhabit by 295.2% in the 1st quarter. GAMMA Investing LLC now owns 3,533 shares of the company’s stock valued at $31,000 after buying an additional 2,639 shares during the period. Quantbot Technologies LP purchased a new stake in Enhabit in the 4th quarter valued at about $45,000. Group One Trading LLC boosted its position in Enhabit by 248.3% in the 4th quarter. Group One Trading LLC now owns 7,746 shares of the company’s stock valued at $60,000 after buying an additional 5,522 shares during the period. Corient Private Wealth LLC purchased a new stake in Enhabit in the 4th quarter valued at about $79,000. Finally, Quarry LP boosted its position in Enhabit by 692.6% in the 4th quarter. Quarry LP now owns 10,811 shares of the company’s stock valued at $84,000 after buying an additional 9,447 shares during the period.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.